During the past decade, Herzzentrum Siegburg GmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Herzzentrum Siegburg GmbH" are "Coronary Artery Disease" (5 trials), "Coronary Disease" (3 trials), "Coronary Restenosis" (3 trials), "Coronary Artery Stenosis" (1 trials) and "Everolimus" (1 trials). Many other conditions were trialed in "Herzzentrum Siegburg GmbH" in a lesser frequency.

Most popular intervention types in "Herzzentrum Siegburg GmbH" are "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Coronary artery drug eluting stent placement" (1 trials), "Coronary artery stent placement" (1 trials), "TAXUS® Liberté™" (1 trials), "TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent System" (1 trials) and "XIENCE V® EECSS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum Siegburg GmbH" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Herzzentrum Siegburg GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Herzzentrum Siegburg GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum Siegburg GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".